Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2178970
Max Phase: Preclinical
Molecular Formula: C29H35N5O3
Molecular Weight: 501.63
Molecule Type: Small molecule
Associated Items:
ID: ALA2178970
Max Phase: Preclinical
Molecular Formula: C29H35N5O3
Molecular Weight: 501.63
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C([C@@H]1C[C@H](n2cc(COCc3ccccc3)nn2)CN1C(=O)CCCc1ccccc1)N1CCCC1
Standard InChI: InChI=1S/C29H35N5O3/c35-28(15-9-14-23-10-3-1-4-11-23)33-20-26(18-27(33)29(36)32-16-7-8-17-32)34-19-25(30-31-34)22-37-21-24-12-5-2-6-13-24/h1-6,10-13,19,26-27H,7-9,14-18,20-22H2/t26-,27-/m0/s1
Standard InChI Key: XYKUHZZLDLVBTI-SVBPBHIXSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 501.63 | Molecular Weight (Monoisotopic): 501.2740 | AlogP: 3.78 | #Rotatable Bonds: 10 |
Polar Surface Area: 80.56 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 0 |
#RO5 Violations: 1 | HBA (Lipinski): 8 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 3.36 | CX LogD: 3.36 |
Aromatic Rings: 3 | Heavy Atoms: 37 | QED Weighted: 0.42 | Np Likeness Score: -1.14 |
1. Van der Veken P, Fülöp V, Rea D, Gerard M, Van Elzen R, Joossens J, Cheng JD, Baekelandt V, De Meester I, Lambeir AM, Augustyns K.. (2012) P2-substituted N-acylprolylpyrrolidine inhibitors of prolyl oligopeptidase: biochemical evaluation, binding mode determination, and assessment in a cellular model of synucleinopathy., 55 (22): [PMID:23121075] [10.1021/jm301060g] |
Source(1):